Siegal AR, Huang Z, Gross MD, et al. - This study was conducted to explore the applicability of mesh slings for stress urinary incontinence (SUI) across time – before and after the 2011 US Food and Drug Administration (FDA) public health notification regarding an increase in adverse events related to transvaginal mesh (TVM) for pelvic organ prolapse (POP) repair – and among FPMRS-certified urologists and gynecologists and non-FPMRS counterparts using a statewide database. Between 2007 and 2015, researchers employed the New York Statewide Planning and Research Cooperative System all-payer database to extract outpatient Current Procedural Terminology procedure codes for SUI mesh sling utilization and revision or removal. The data demonstrated that the applicability of mesh slings for SUI has significantly reduced since the 2011 FDA public health notification, without any specific warning for the utilization of mesh in this setting in New York state. Among non-FPMRS physicians, this trend was mainly driven by a decrease in mesh usage, although the specific causality is likely complex.